Evommune, Inc.

Healthcare

NYSE:EVMN · New York Stock Exchange

Market Cap $292.49M Beta 0.10 P/E (TTM) -9.1

$21.36 -0.82%

-$0.17 today

52W Low $13.89High $33.20

Vol 0.48M · Avg 0.38M

EPS (TTM) -$2.26Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+5.59%

Period High

$31.57

Period Low

$15.01

Latest

$21.36

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Ligand Pharmaceuticals Incorporated

NASDAQ:LGND

$5.46B

Galapagos N.V.

GLPG

$1.84B

Zymeworks Inc.

NASDAQ:ZYME

$1.69B

Fortrea Holdings Inc.

NASDAQ:FTRE

$1.44B

EyePoint Pharmaceuticals, Inc.

NASDAQ:EYPT

$1.12B

Climb Bio, Inc.

NASDAQ:CLYM

$779.01M

OmniAb, Inc.

NASDAQ:OABI

$262.00M

Artiva Biotherapeutics, Inc.

NASDAQ:ARTV

$238.63M

Codexis, Inc.

NASDAQ:CDXS

$225.88M

Karyopharm Therapeutics Inc.

NASDAQ:KPTI

$209.63M

What is the latest EVMN filing?

The latest filing shown is 8-K dated Jun 15, 2026.

How many recent filings does EVMN have?

Intrinsic Alpha currently shows 20 recent filings for EVMN.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.